IBI-334

CAT: 0804-HY-P991092Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-P991092Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
IBI-334 is a bispecific B7-H3 and EGFR antibody. IBI-334 has an EGFR arm for signal blockage and is coupled with a fine-tuned B7-H3 arm with optimal affinity and binding domain. IBI-334 is afucosylated to enhance its antibody-mediated cell cytotoxicity (ADCC) effects. IBI-334 has a wide range of applications in many EGFR-driven solid tumors[1].
UNSPSC
12352203
Target
CD276/B7-H3; EGFR
Related Pathways
Immunology/Inflammation; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
[IBI-334]
References & Citations
[1]Jian Guan, et al. Abstract LB056: IBI334, a novel ADCC-enhanced B7-H3/EGFR bispecific antibody, demonstrated potent pre-clinical efficacy in solid tumors. Cancer Res (2024) 84 (7_Supplement) : LB056.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Related Products

CatalogName
HY-P991366IBI-397
HY-P991740IBI-363
HY-P991634IBI-325
HY-110295SPL-334
HY-W180804-01Coumarin 334
HY-126956Porphyra 334
HY-W953743CRBN ligand-334
HY-D1005A20Poloxamer 334 (P104)
HY-P10554-01Myhc-α (334–352)

Alternative Products

CatalogName
T9901A-802-01IBI-334
C00906Ibi-334 (Anti-B7-H3 & EGFR)
BIO1006SM-1mgAnti-human B7-H3 & EGFR (Ibi-334 Biosimilar)
HV612086-01Research Grade Anti-B7-H3 & EGFR Bispecific Antibody (Ibi-334)
T9901A-1578-01IBI-322
T9901A-1576-01IBI-397
T9901A-1902-01IBI-325
A137326Anti-B7-H3 & EGFR Bispecific Antibody (Ibi-334) Biosimilar (Monoclonal, IgG-like)
IB47602IBI ISOLATE TOTAL EXTRACTION
IB70070IBI BASIC AGAROSE-100GM

Popular Products